| Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite G Renga, E Nunzi, M Pariano, M Puccetti, MM Bellet, G Pieraccini, ... Journal for immunotherapy of cancer 10 (3), 2022 | 48 | 2022 |
| A reappraisal of thymosin alpha1 in cancer therapy C Costantini, MM Bellet, M Pariano, G Renga, C Stincardini, AL Goldstein, ... Frontiers in oncology 9, 873, 2019 | 48 | 2019 |
| A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein T Massignan, S Cimini, C Stincardini, M Cerovic, I Vanni, SR Elezgarai, ... Scientific Reports 6 (1), 23180, 2016 | 45 | 2016 |
| Microbes in the era of circadian medicine C Costantini, G Renga, F Sellitto, M Borghi, C Stincardini, M Pariano, ... Frontiers in cellular and infection microbiology 10, 30, 2020 | 44 | 2020 |
| Targeting the aryl hydrocarbon receptor with indole-3-aldehyde protects from vulvovaginal candidiasis via the IL-22-IL-18 cross-talk M Borghi, M Pariano, V Solito, M Puccetti, MM Bellet, C Stincardini, ... Frontiers in immunology 10, 2364, 2019 | 35 | 2019 |
| Indole-3-carboxaldehyde restores gut mucosal integrity and protects from liver fibrosis in murine sclerosing cholangitis F D’Onofrio, G Renga, M Puccetti, M Pariano, MM Bellet, I Santarelli, ... Cells 10 (7), 1622, 2021 | 27 | 2021 |
| Thymosin β4 limits inflammation through autophagy G Renga, V Oikonomou, C Stincardini, M Pariano, M Borghi, C Costantini, ... Expert opinion on biological therapy 18 (sup1), 171-175, 2018 | 27 | 2018 |
| Towards targeting the aryl hydrocarbon receptor in cystic fibrosis M Puccetti, G Paolicelli, V Oikonomou, A De Luca, G Renga, M Borghi, ... Mediators of Inflammation 2018, 2018 | 26 | 2018 |
| Tryptophan co-metabolism at the host-pathogen interface C Costantini, MM Bellet, G Renga, C Stincardini, M Borghi, M Pariano, ... Frontiers in immunology 11, 505434, 2020 | 25 | 2020 |
| Tryptophan as a central hub for host/microbial symbiosis M Borghi, M Puccetti, M Pariano, G Renga, C Stincardini, M Ricci, ... International Journal of Tryptophan Research 13, 1178646920919755, 2020 | 23 | 2020 |
| An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein C Stincardini, T Massignan, S Biggi, SR Elezgarai, V Sangiovanni, I Vanni, ... PloS one 12 (8), e0182589, 2017 | 23 | 2017 |
| Anakinra activates superoxide dismutase 2 to mitigate inflammasome activity M Pariano, S Pieroni, A De Luca, RG Iannitti, M Borghi, M Puccetti, ... International Journal of Molecular Sciences 22 (12), 6531, 2021 | 18 | 2021 |
| The circadian protein PER1 modulates the cellular response to anticancer treatments MM Bellet, C Stincardini, C Costantini, M Gargaro, S Pieroni, M Castelli, ... International Journal of Molecular Sciences 22 (6), 2974, 2021 | 18 | 2021 |
| Thymosin β4 promotes autophagy and repair via HIF-1α stabilization in chronic granulomatous disease G Renga, V Oikonomou, S Moretti, C Stincardini, MM Bellet, M Pariano, ... Life science alliance 2 (6), 2019 | 18 | 2019 |
| Genetic polymorphisms affecting IDO1 or IDO2 activity differently associate with aspergillosis in humans V Napolioni, M Pariano, M Borghi, V Oikonomou, C Galosi, A De Luca, ... Frontiers in immunology 10, 890, 2019 | 18 | 2019 |
| Thymosin α1 protects from CTLA-4 intestinal immunopathology G Renga, MM Bellet, M Pariano, M Gargaro, C Stincardini, F D’Onofrio, ... Life Science Alliance 3 (10), 2020 | 17 | 2020 |
| Autophagy and LAP in the fight against fungal infections: Regulation and therapeutics V Oikonomou, G Renga, A De Luca, M Borghi, M Pariano, M Puccetti, ... Mediators of inflammation 2018, 2018 | 17 | 2018 |
| Targeted drug delivery technologies potentiate the overall therapeutic efficacy of an indole derivative in a mouse cystic fibrosis setting M Puccetti, M Pariano, G Renga, I Santarelli, F D’Onofrio, MM Bellet, ... Cells 10 (7), 1601, 2021 | 16 | 2021 |
| Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface S Biggi, M Pancher, C Stincardini, S Luotti, T Massignan, A Dalle Vedove, ... Journal of Neurochemistry 152 (1), 136-150, 2020 | 14 | 2020 |
| Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases N Iraci, C Stincardini, ML Barreca, E Biasini Virus research 207, 62-68, 2015 | 12 | 2015 |
